scholarly journals Atrial Fibrillation Ablation in Heart Failure Patients

2021 ◽  
Vol 10 (16) ◽  
pp. 3512
Author(s):  
Michael Derndorfer ◽  
Shaojie Chen ◽  
Helmut Pürerfellner
Keyword(s):  
Quality Of Life ◽  
Heart Failure ◽  
Atrial Fibrillation ◽  
Side Effects ◽  
Meta Analysis ◽  
Treatment Options ◽  
Rhythm Control ◽  
The Other ◽  
Heart Failure Patients

Atrial Fibrillation (AF) and Heart Failure (HF) are closely linked to each other, as each can be either the cause of or the result of the other. Successfully treating one of the two entities means laying the basis for treating the other one as well. Management of patients with AF and HF can be challenging and should primarily adhere to available guidelines. Concerning AF, medication is limited and causes many side effects, leading to low medical adherence. Several smaller studies, summarized in a big meta-analysis, provide evidence that ablation of AF in HF patients is crucial for improving quality of life, reducing HF hospitalizations, and reducing death, provided the LVEF is at least 25% or higher. In advanced HF, alternative treatment options (including assist devices, heart transplant) might still be the better option. Early rhythm control should be taken into consideration, as there is evidence that it is associated with better cardiovascular outcome.

Quality of life of chronic heart failure patients: a systematic review and meta-analysis

2019 ◽  
Vol 25 (6) ◽  
pp. 993-1006 ◽  
Author(s):  
Mandana Moradi ◽  
Fereshteh Daneshi ◽  
Razieh Behzadmehr ◽  
Hosien Rafiemanesh ◽  
Salehoddin Bouya ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Heart Failure ◽  
Systematic Review ◽  
Chronic Heart Failure ◽  
Meta Analysis ◽  
Heart Failure Patients

scholarly journals Cabins, castles, and constant hearts: rhythm control therapy in patients with atrial fibrillation

2019 ◽  
Vol 40 (46) ◽  
pp. 3793-3799c ◽  
Author(s):  
Stephan Willems ◽  
Christian Meyer ◽  
Joseph de Bono ◽  
Axel Brandes ◽  
Lars Eckardt ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Heart Failure ◽  
Atrial Fibrillation ◽  
Left Ventricular Function ◽  
Antiarrhythmic Drugs ◽  
Left Ventricular ◽  
Rhythm Control ◽  
Af Ablation ◽  
Control Therapy

Abstract Recent innovations have the potential to improve rhythm control therapy in patients with atrial fibrillation (AF). Controlled trials provide new evidence on the effectiveness and safety of rhythm control therapy, particularly in patients with AF and heart failure. This review summarizes evidence supporting the use of rhythm control therapy in patients with AF for different outcomes, discusses implications for indications, and highlights remaining clinical gaps in evidence. Rhythm control therapy improves symptoms and quality of life in patients with symptomatic AF and can be safely delivered in elderly patients with comorbidities (mean age 70 years, 3–7% complications at 1 year). Atrial fibrillation ablation maintains sinus rhythm more effectively than antiarrhythmic drug therapy, but recurrent AF remains common, highlighting the need for better patient selection (precision medicine). Antiarrhythmic drugs remain effective after AF ablation, underpinning the synergistic mechanisms of action of AF ablation and antiarrhythmic drugs. Atrial fibrillation ablation appears to improve left ventricular function in a subset of patients with AF and heart failure. Data on the prognostic effect of rhythm control therapy are heterogeneous without a clear signal for either benefit or harm. Rhythm control therapy has acceptable safety and improves quality of life in patients with symptomatic AF, including in elderly populations with stroke risk factors. There is a clinical need to better stratify patients for rhythm control therapy. Further studies are needed to determine whether rhythm control therapy, and particularly AF ablation, improves left ventricular function and reduces AF-related complications.

scholarly journals Quality of life and heart rate according to the presence of sinus rhythm or atrial fibrillation in heart failure patients

2013 ◽  
Vol 34 (suppl 1) ◽  
pp. P642-P642
Author(s):  
M. De Antonio ◽  
J. Lupon ◽  
M. Domingo ◽  
R. Cabanes ◽  
B. Gonzalez ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Heart Failure ◽  
Atrial Fibrillation ◽  
Heart Rate ◽  
Sinus Rhythm ◽  
Heart Failure Patients

The effect of beta-blocker therapy on quality of life in heart failure patients: a systematic review and meta-analysis

2006 ◽  
Vol 16 (2) ◽  
pp. 152-159 ◽  
Author(s):  
Daniela Dobre ◽  
Cornelia H. M. van Jaarsveld ◽  
Mike J. L. deJongste ◽  
Flora M. Haaijer Ruskamp ◽  
Adelita V. Ranchor
Keyword(s):  
Quality Of Life ◽  
Heart Failure ◽  
Systematic Review ◽  
Beta Blocker ◽  
Meta Analysis ◽  
Blocker Therapy ◽  
Heart Failure Patients ◽  
Beta Blocker Therapy

scholarly journals Efektivitas Terapi Komplementer Dalam Meningkatkan Kualitas Hidup Pada Pasien Gagal Jantung: Systematic Review

2020 ◽  
Vol 5 (2) ◽  
Author(s):  
Toar Calvin Christo Paat ◽  
Kadek Ayu Erika ◽  
Arianty Saleh
Keyword(s):  
Quality Of Life ◽  
Heart Failure ◽  
Systematic Review ◽  
Meta Analysis ◽  
Exercise Program ◽  
Complementary Therapy ◽  
Assessment Instrument ◽  
Breathing Patterns ◽  
Heart Failure Patients

Introduction: The prevalence of heart failure patients is increasing along with the increase in the global population. Poor quality of life is one of the characteristics of heart failure patients. Complementary therapy might be an alternative to overcome them.. Methods:  The design of this study is a systematic review using the Preferred reporting items for systematic review and meta analysis (PRISMA) method to compile this paper. The article were collected from online database included PubMed, Science Direct and Google Scholar and publish in 2010 to 2020. Determined articles about intervention articles that discuss the effectiveness of complementary therapies to improve quality of life in heart failure patients.Results:  Six articles were identified and determined to conduct this systematic review. All studies were conducted using intervention trials of complementary therapy to increase quality of life. Those therapy included Music therapy, a walking exercise program with regulates breathing patterns, benson relaxation, yoga practice, tai chi. These therapy provided by trained nurse. The duration of administration is from 15 minutes to 60 minutes for 3 days to 14 weeks. MLHFQ is the most widely used assessment instrument, the rest are EuroQol, KCCQ and WHOQOL. All studies revealed the significance improvement of quality of life.Conclusion:  It is conclude that complementary therapy showed strong evidence to improve the quality of life in heart failure patients. in practice, official standard procedures are needed.

Sign in / Sign up

Export Citation Format

Share Document